| http://www.w3.org/ns/prov#value | - They found the NMO-IgG autoantibody in nearly three-quarters of people with NMO, in nearly one-half of people whose symptoms were classified as being at high risk for developing NMO, and in none of those diagnosed with MS or other neurological or autoimmune disorders.
|
